BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10364825)

  • 1. Characterization of the lysinuric protein intolerance (LPI) region within T-cell receptor alpha/delta gene cluster on chromosome site 14q11.
    Lauteala T; Mykkänen J; Horelli-Kuitunen N; Aaltonen J; Paavola P; Savontaus ML; Simell O; Aula P
    Hereditas; 1999; 130(1):19-24. PubMed ID: 10364825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic homogeneity of lysinuric protein intolerance.
    Lauteala T; Mykkänen J; Sperandeo MP; Gasparini P; Savontaus ML; Simell O; Andria G; Sebastio G; Aula P
    Eur J Hum Genet; 1998; 6(6):612-5. PubMed ID: 9887380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cationic amino acid transporter gene hCAT-2 is assigned to 8p22 but is not the causative gene in lysinuric protein intolerance.
    Lauteala T; Horelli-Kuitunen N; Closs E; Savontaus MI; Lukkarinen M; Simell O; Cunningham J; Palotie A; Aula P
    Hum Genet; 1997 Jul; 100(1):80-3. PubMed ID: 9225973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysinuric protein intolerance (LPI) gene maps to the long arm of chromosome 14.
    Lauteala T; Sistonen P; Savontaus ML; Mykkänen J; Simell J; Lukkarinen M; Simell O; Aula P
    Am J Hum Genet; 1997 Jun; 60(6):1479-86. PubMed ID: 9199570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of prenatal diagnosis of lysinuric protein intolerance by linkage analysis: a case report.
    Sperandeo MP; Buoninconti A; Passariello A; Scala I; Adami A; Lauteala T; Mykkänen J; Andria G; Sebastio G
    Prenat Diagn; 1999 Aug; 19(8):771-3. PubMed ID: 10451527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance.
    Borsani G; Bassi MT; Sperandeo MP; De Grandi A; Buoninconti A; Riboni M; Manzoni M; Incerti B; Pepe A; Andria G; Ballabio A; Sebastio G
    Nat Genet; 1999 Mar; 21(3):297-301. PubMed ID: 10080183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of novel mutations in y(+)LAT-1 amino acid transporter gene causing lysinuric protein intolerance (LPI).
    Mykkänen J; Torrents D; Pineda M; Camps M; Yoldi ME; Horelli-Kuitunen N; Huoponen K; Heinonen M; Oksanen J; Simell O; Savontaus ML; Zorzano A; Palacín M; Aula P
    Hum Mol Genet; 2000 Feb; 9(3):431-8. PubMed ID: 10655553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene.
    Torrents D; Mykkänen J; Pineda M; Feliubadaló L; Estévez R; de Cid R; Sanjurjo P; Zorzano A; Nunes V; Huoponen K; Reinikainen A; Simell O; Savontaus ML; Aula P; Palacín M
    Nat Genet; 1999 Mar; 21(3):293-6. PubMed ID: 10080182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of a membrane protein (y+L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y+L. A candidate gene for lysinuric protein intolerance.
    Torrents D; Estévez R; Pineda M; Fernández E; Lloberas J; Shi YB; Zorzano A; Palacín M
    J Biol Chem; 1998 Dec; 273(49):32437-45. PubMed ID: 9829974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC7A8, a gene mapping within the lysinuric protein intolerance critical region, encodes a new member of the glycoprotein-associated amino acid transporter family.
    Bassi MT; Sperandeo MP; Incerti B; Bulfone A; Pepe A; Surace EM; Gattuso C; De Grandi A; Buoninconti A; Riboni M; Manzoni M; Andria G; Ballabio A; Borsani G; Sebastio G
    Genomics; 1999 Dec; 62(2):297-303. PubMed ID: 10610726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysinuric protein intolerance mutation is not expressed in the plasma membrane of erythrocytes.
    Smith DW; Scriver CR; Simell O
    Hum Genet; 1988 Dec; 80(4):395-6. PubMed ID: 3143662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imbalance of plasma amino acids, metabolites and lipids in patients with lysinuric protein intolerance (LPI).
    Kurko J; Tringham M; Tanner L; Näntö-Salonen K; Vähä-Mäkilä M; Nygren H; Pöhö P; Lietzen N; Mattila I; Olkku A; Hyötyläinen T; Orešič M; Simell O; Niinikoski H; Mykkänen J
    Metabolism; 2016 Sep; 65(9):1361-75. PubMed ID: 27506743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysinuric protein intolerance with homozygous SLC7A7 mutation caused by maternal uniparental isodisomy of chromosome 14.
    Kang E; Kim T; Oh A; Yum MS; Keum C; Yoo HW; Lee BH
    J Hum Genet; 2019 Nov; 64(11):1137-1140. PubMed ID: 31427715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cluster of lysinuric protein intolerance (LPI) patients in a northern part of Iwate, Japan due to a founder effect. The Mass Screening Group.
    Koizumi A; Shoji Y; Nozaki J; Noguchi A; E X; Dakeishi M; Ohura T; Tsuyoshi K; Yasuhiko W; Manabe M; Takasago Y; Takada G
    Hum Mutat; 2000 Sep; 16(3):270-1. PubMed ID: 10980538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLC7A7 genomic structure and novel variants in three Japanese lysinuric protein intolerance families.
    Noguchi A; Shoji Y; Koizumi A; Takahashi T; Matsumori M; Kayo T; Ohata T; Wada Y; Yoshimura I; Maisawa S; Konishi M; Takasago Y; Takada G
    Hum Mutat; 2000; 15(4):367-72. PubMed ID: 10737982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of LPI-causing mutations on y+LAT1 function and localization.
    Rotoli BM; Barilli A; Ingoglia F; Visigalli R; Bianchi MG; Ferrari F; Martinelli D; Dionisi-Vici C; Dall'Asta V
    Orphanet J Rare Dis; 2019 Mar; 14(1):63. PubMed ID: 30832686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysine fluxes across the jejunal epithelium in lysinuric protein intolerance.
    Desjeux JF; Simell RO; Dumontier AM; Perheentupa J
    J Clin Invest; 1980 Jun; 65(6):1382-7. PubMed ID: 6773985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired phagocytosis in macrophages from patients affected by lysinuric protein intolerance.
    Barilli A; Rotoli BM; Visigalli R; Bussolati O; Gazzola GC; Gatti R; Dionisi-Vici C; Martinelli D; Goffredo BM; Font-Llitjós M; Mariani F; Luisetti M; Dall'Asta V
    Mol Genet Metab; 2012 Apr; 105(4):585-9. PubMed ID: 22325938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving a Rare Metabolic Disorder Through Kidney Transplantation: A Case Report of a Patient With Lysinuric Protein Intolerance.
    IJzermans T; van der Meijden W; Hoeks M; Huigen M; Rennings A; Nijenhuis T
    Am J Kidney Dis; 2023 Apr; 81(4):493-496. PubMed ID: 36223829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the transcriptomic variation caused by the Finnish founder mutation of lysinuric protein intolerance (LPI).
    Tringham M; Kurko J; Tanner L; Tuikkala J; Nevalainen OS; Niinikoski H; Näntö-Salonen K; Hietala M; Simell O; Mykkänen J
    Mol Genet Metab; 2012 Mar; 105(3):408-15. PubMed ID: 22221392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.